RNA modification is an area of cell biology few people have studied, and the idea of exploring the boundaries of the known world is what first attracted graduate student Archana Yerra to a career in science.
"cancer research" News
Our bodies fight cancer more than we really know, says Kenneth Grossmann, MD, PhD, a medical oncologist at Huntsman Cancer Institute (HCI) and assistant professor of dermatology at the University of Utah (U of U). And, he adds, advances in medicine can help the immune system fight cancer even better.
Huntsman Cancer Institute began in 1995 with an empty lot and a dream full of promise. Twenty-two years later, HCI is opening a major expansion that will double its research capacity.
Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah testified before the United States House of Representatives Committee on Oversight and Government Reform. She spoke on the impact of federally-funded cancer research. Beckerle was invited to testify at this bipartisan hearing by Chairman Jason Chaffetz and Ranking Member Elijah Cummings.
Huntsman Cancer Institute (HCI) researcher Andrew Hahn, MD, received an award for his work in genitourinary cancers from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The Conquer Cancer Foundation of ASCO Merit Award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.
The 21st Century Cures Act, signed into law in December 2016, includes $4.8 billion to fund research and drug development. The law provided funds for a number of initiatives, including the “Cancer Moonshot” effort, which seeks to accelerate cancer research in the United States. Cancer researchers at HCI urge the community to continue to support biomedical research in order to develop safe and effective disease treatments.